Logo image of OKUR

ONKURE THERAPEUTICS INC-A (OKUR) Stock Overview

NASDAQ:OKUR - US68277Q1058 - Common Stock

2.75 USD
+0.06 (+2.23%)
Last: 9/5/2025, 8:00:02 PM

OKUR Key Statistics, Chart & Performance

Key Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap37.21M
Shares13.53M
Float12.14M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-4.8
PEN/A
Fwd PEN/A
Earnings (Next)11-05 2025-11-05/bmo
IPO04-09 2021-04-09
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


OKUR short term performance overview.The bars show the price performance of OKUR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 -40

OKUR long term performance overview.The bars show the price performance of OKUR in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of OKUR is 2.75 USD. In the past month the price increased by 36.82%.

ONKURE THERAPEUTICS INC-A / OKUR Daily stock chart

OKUR Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 20.07 375.50B
AMGN AMGEN INC 13.01 152.70B
GILD GILEAD SCIENCES INC 14.86 142.76B
VRTX VERTEX PHARMACEUTICALS INC 23.38 101.56B
REGN REGENERON PHARMACEUTICALS 12.56 60.77B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 59.25B
ARGX ARGENX SE - ADR 80.99 45.95B
ONC BEONE MEDICINES LTD-ADR 5.99 40.63B
INSM INSMED INC N/A 30.67B
BNTX BIONTECH SE-ADR N/A 27.03B
NTRA NATERA INC N/A 23.06B
BIIB BIOGEN INC 8.79 20.62B

About OKUR

Company Profile

OKUR logo image OnKure Therapeutics, Inc. engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company is headquartered in Boulder, Colorado and currently employs 46 full-time employees. The company went IPO on 2021-04-09. Using a structure-based drug design platform, the Company is building a pipeline of tumor-agnostic candidates. The company is developing OKI-219, a selective PI3KaH1047R inhibitor, as its lead program. The company is engaged in targeting oncogenic PI3Ka and has multiple programs designed to enable targeting of this key oncogene. The company is focused on delivering highly selective drug candidates that preserve wild-type PI3Ka while targeting the PI3Ka-mutated cancers, initially in advanced breast cancer. Its lead product candidate, OKI-219, is advancing in a phase I clinical trial. The company also focuses on a development candidate targeting the most common PI3Ka mutations, such as H1047R, E545K, and E542K. Additionally, it is developing an allosteric inhibitor molecule.

Company Info

ONKURE THERAPEUTICS INC-A

6707 Winchester Circle, Suite 400

Boulder COLORADO US

Employees: 46

OKUR Company Website

OKUR Investor Relations

Phone: 17203072892

ONKURE THERAPEUTICS INC-A / OKUR FAQ

What is the stock price of ONKURE THERAPEUTICS INC-A today?

The current stock price of OKUR is 2.75 USD. The price increased by 2.23% in the last trading session.


What is the ticker symbol for ONKURE THERAPEUTICS INC-A stock?

The exchange symbol of ONKURE THERAPEUTICS INC-A is OKUR and it is listed on the Nasdaq exchange.


On which exchange is OKUR stock listed?

OKUR stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ONKURE THERAPEUTICS INC-A stock?

12 analysts have analysed OKUR and the average price target is 30.6 USD. This implies a price increase of 1012.73% is expected in the next year compared to the current price of 2.75. Check the ONKURE THERAPEUTICS INC-A stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ONKURE THERAPEUTICS INC-A worth?

ONKURE THERAPEUTICS INC-A (OKUR) has a market capitalization of 37.21M USD. This makes OKUR a Nano Cap stock.


How many employees does ONKURE THERAPEUTICS INC-A have?

ONKURE THERAPEUTICS INC-A (OKUR) currently has 46 employees.


What are the support and resistance levels for ONKURE THERAPEUTICS INC-A (OKUR) stock?

ONKURE THERAPEUTICS INC-A (OKUR) has a support level at 2.68 and a resistance level at 2.78. Check the full technical report for a detailed analysis of OKUR support and resistance levels.


Should I buy ONKURE THERAPEUTICS INC-A (OKUR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ONKURE THERAPEUTICS INC-A (OKUR) stock pay dividends?

OKUR does not pay a dividend.


When does ONKURE THERAPEUTICS INC-A (OKUR) report earnings?

ONKURE THERAPEUTICS INC-A (OKUR) will report earnings on 2025-11-05, before the market open.


What is the Price/Earnings (PE) ratio of ONKURE THERAPEUTICS INC-A (OKUR)?

ONKURE THERAPEUTICS INC-A (OKUR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.8).


What is the Short Interest ratio of ONKURE THERAPEUTICS INC-A (OKUR) stock?

The outstanding short interest for ONKURE THERAPEUTICS INC-A (OKUR) is 1.89% of its float. Check the ownership tab for more information on the OKUR short interest.


OKUR Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to OKUR.


Chartmill TA Rating
Chartmill Setup Rating

OKUR Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to OKUR. No worries on liquidiy or solvency for OKUR as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

OKUR Financial Highlights

Over the last trailing twelve months OKUR reported a non-GAAP Earnings per Share(EPS) of -4.8. The EPS increased by 10.78% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -81.56%
ROE -89.81%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%28.75%
Sales Q2Q%N/A
EPS 1Y (TTM)10.78%
Revenue 1Y (TTM)N/A

OKUR Forecast & Estimates

12 analysts have analysed OKUR and the average price target is 30.6 USD. This implies a price increase of 1012.73% is expected in the next year compared to the current price of 2.75.


Analysts
Analysts85
Price Target30.6 (1012.73%)
EPS Next Y28.97%
Revenue Next YearN/A

OKUR Ownership

Ownership
Inst Owners86.61%
Ins Owners1.56%
Short Float %1.89%
Short Ratio2.5